发明名称 TREATMENT METHOD FOR PRIMARY HEMOSTASIA DISORDERS IN METABOLIC SYNDROME PATIENTS
摘要 FIELD: medicine. ^ SUBSTANCE: individually chosen low-calorie diet, 60 mg dilthyasem twice a day, and 6.21 mg spirapril every morning, are administered. ^ EFFECT: primary hemostasia normalisation, significantly decreasing risk of thrombosis complications in metabolic syndrome. ^ 1 ex
申请公布号 RU2342137(C2) 申请公布日期 2008.12.27
申请号 RU20070107532 申请日期 2007.02.28
申请人 MEDVEDEV IL'JA NIKOLAEVICH;BESPARTOCHNYJ BORIS DMITRIEVICH 发明人 MEDVEDEV IL'JA NIKOLAEVICH;BESPARTOCHNYJ BORIS DMITRIEVICH
分类号 A61K31/401;A61K31/554;A61P7/00 主分类号 A61K31/401
代理机构 代理人
主权项
地址